Hamdy A. Azim

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Jens Huober, Peter A. Fasching, M. Barsoum et al. · The Breast · 2011 · 226 citations · Full text

Biology of breast cancer during pregnancy using genomic profiling

Hamdy A. Azim, S. Brohée, Fedro A. Peccatori et al. · Endocrine Related Cancer · 2014 · 68 citations · Full text

Breast Oncology, Engineering, Cancer Pathology +17

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 65 citations · Full text

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

Breast cancer in Egypt, China and Chinese: statistics and beyond.

Hamdy A. Azim, Amal Ibrahim · PubMed · 2014 · 42 citations · Full text

Bc Statistics, Breast Oncology, Epidemiology Of Cancer +19